[go: up one dir, main page]

GB201020300D0 - Product - Google Patents

Product

Info

Publication number
GB201020300D0
GB201020300D0 GBGB1020300.8A GB201020300A GB201020300D0 GB 201020300 D0 GB201020300 D0 GB 201020300D0 GB 201020300 A GB201020300 A GB 201020300A GB 201020300 D0 GB201020300 D0 GB 201020300D0
Authority
GB
United Kingdom
Prior art keywords
cardiopulmonary bypass
relates
present
oncotic
priming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1020300.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vitrolife Sweden AB
Original Assignee
Vitrolife Sweden AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitrolife Sweden AB filed Critical Vitrolife Sweden AB
Priority to GBGB1020300.8A priority Critical patent/GB201020300D0/en
Publication of GB201020300D0 publication Critical patent/GB201020300D0/en
Priority to PL11788089T priority patent/PL2646040T3/en
Priority to EP11788089.8A priority patent/EP2646040B1/en
Priority to JP2013541272A priority patent/JP6051164B2/en
Priority to RU2013127665/15A priority patent/RU2013127665A/en
Priority to DK11788089.8T priority patent/DK2646040T3/en
Priority to PCT/EP2011/069524 priority patent/WO2012072374A1/en
Priority to ES11788089.8T priority patent/ES2575206T3/en
Priority to US13/634,934 priority patent/US8969323B2/en
Priority to CN201180056991.XA priority patent/CN103228285B/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)

Abstract

The present invention relates to priming solutions used during cardiopulmonary bypass procedures. In particular, the present invention relates to a cardiopulmonary bypass priming solution comprising a balanced salt solution and a combination of oncotic and non-oncotic dextran molecules. The present invention also relates to the use of the priming solution in a cardiopulmonary bypass method, a method of maintaining oncotic pressure in a patient during a cardiopulmonary bypass procedure, and a combination of cardiopulmonary bypass priming solution and cardiopulmonary bypass apparatus.
GBGB1020300.8A 2010-11-30 2010-11-30 Product Ceased GB201020300D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB1020300.8A GB201020300D0 (en) 2010-11-30 2010-11-30 Product
CN201180056991.XA CN103228285B (en) 2010-11-30 2011-11-07 Primer for cardiopulmonary bypass
RU2013127665/15A RU2013127665A (en) 2010-11-30 2011-11-07 SOLUTION FOR PRIMARY FILLING OF THE ARTIFICIAL BLOOD CIRCULATION APPARATUS
EP11788089.8A EP2646040B1 (en) 2010-11-30 2011-11-07 Priming solutions for cardiopulmonary bypass
JP2013541272A JP6051164B2 (en) 2010-11-30 2011-11-07 Priming fluid for cardiopulmonary bypass
PL11788089T PL2646040T3 (en) 2010-11-30 2011-11-07 Priming solutions for cardiopulmonary bypass
DK11788089.8T DK2646040T3 (en) 2010-11-30 2011-11-07 CARDIOPULMONAL BYPASS PRIMING SOLUTIONS
PCT/EP2011/069524 WO2012072374A1 (en) 2010-11-30 2011-11-07 Priming solutions for cardiopulmonary bypass
ES11788089.8T ES2575206T3 (en) 2010-11-30 2011-11-07 Priming solutions for cardiopulmonary bypass
US13/634,934 US8969323B2 (en) 2010-11-30 2011-11-07 Priming solutions for cardiopulmonary bypass

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1020300.8A GB201020300D0 (en) 2010-11-30 2010-11-30 Product

Publications (1)

Publication Number Publication Date
GB201020300D0 true GB201020300D0 (en) 2011-01-12

Family

ID=43500877

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1020300.8A Ceased GB201020300D0 (en) 2010-11-30 2010-11-30 Product

Country Status (10)

Country Link
US (1) US8969323B2 (en)
EP (1) EP2646040B1 (en)
JP (1) JP6051164B2 (en)
CN (1) CN103228285B (en)
DK (1) DK2646040T3 (en)
ES (1) ES2575206T3 (en)
GB (1) GB201020300D0 (en)
PL (1) PL2646040T3 (en)
RU (1) RU2013127665A (en)
WO (1) WO2012072374A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2751767T3 (en) 2017-01-17 2020-04-01 Xvivo Perfusion Ab Organ preservation and / or perfusion solutions
US11707600B2 (en) * 2020-11-18 2023-07-25 CardioDriven, Inc. Level set calibration and assurance for pulmonary artery pressure catheterization
CN117481629B (en) * 2023-12-29 2024-03-26 成都水木医疗科技有限公司 Multifunctional colloid osmotic pressure instrument and measuring method and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1594697A (en) 1977-04-19 1981-08-05 Pharmacia Ab Oligosaccharide compositions for parenteral use
SE8900586L (en) * 1989-02-21 1990-08-22 Pharmacia Ab COMPOSITION AND PROCEDURES TO PREVENT ADHESION BETWEEN BODY TISSUE
ATE199626T1 (en) 1993-06-04 2001-03-15 Biotime Inc PLASMA-LIKE SOLUTION
SE505499C2 (en) * 1995-12-15 1997-09-08 Stiftelsen Facthor Storage solution for organs and tissues or parts thereof of humans and animals containing calcium and nitroglycerin, their use and method of storage therewith
US6794124B2 (en) 1995-12-15 2004-09-21 Stiftelsen Facthor Preservation solution
US5902800A (en) 1998-03-27 1999-05-11 Glenpharma Dextran formulations and method for treatment of inflammatory joint disorders

Also Published As

Publication number Publication date
CN103228285A (en) 2013-07-31
RU2013127665A (en) 2015-01-10
EP2646040A1 (en) 2013-10-09
US8969323B2 (en) 2015-03-03
US20130316977A1 (en) 2013-11-28
JP2013544265A (en) 2013-12-12
PL2646040T3 (en) 2017-04-28
EP2646040B1 (en) 2016-03-23
WO2012072374A1 (en) 2012-06-07
ES2575206T3 (en) 2016-06-27
JP6051164B2 (en) 2016-12-27
DK2646040T3 (en) 2016-06-13
CN103228285B (en) 2016-06-01

Similar Documents

Publication Publication Date Title
BR112013026319A2 (en) method and apparatus for monitoring a patient's treatment, preferably for monitoring hemodialysis, hemodiafiltration and / or peritoneal dialysis
DK3311827T3 (en) NANOPARTICLES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF AS CARRIERS FOR AMPHIPATHIC OR HYDROPHOBIC MOLECULES IN THE MEDICAL FIELD, INCLUDING CANCER TREATMENT, AS WELL AS FOOD-RELATED COMPOUNDS
PH12015501291B1 (en) Functionalized exendin-4 derivatives
AU2011328009A8 (en) Compounds and methods for treating pain
HK1220151A1 (en) Method and apparatus for drug delivery to a target site
WO2010091376A3 (en) Devices and methods for perfusion therapy
MX2014004320A (en) Method and apparatus for treating a patient by intentionally occluding a blood vessel, including method and apparatus for inducing weight loss in a patient by intentionally occluding the celiac artery.
EP2741806A4 (en) Method and apparatus for the dialysis of blood
WO2012158437A3 (en) Cannula apparatus and ventricular assist systems using the cannula apparatus
WO2013022740A3 (en) Gpr35 ligands and the uses thereof
PL3260865T3 (en) Method for the treatment of blood, blood products and organs
PH12016502150A1 (en) Method for treating renal cell carcimona
MX2014010940A (en) The use of antithrombin in the treatment of pre-eclampsia.
EP4403220A3 (en) Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
EP4249056A3 (en) Method for treating heart failure
GB201020300D0 (en) Product
EP2667906A1 (en) Hose pump and blood treatment device equipped therewith
MX348758B (en) Sanglifehrin derivatives and methods for their production.
HK1194912A2 (en) Growth factor concentrate and the use thereof
PH12014500973A1 (en) Phosphatidylinositol 3-kinase inhibitors for the treatment of lymphoproliferative malignancies
EA201301080A1 (en) APPLICATION OF SALTS OF 3-CARBOXY-N-ETHYL-N, N-DIMETHYLPROPAN-1-AMMONIUM IN TREATMENT OF CARDIOVASCULAR DISEASE
WO2013052933A3 (en) Myosin binding protein- c for use in methods relating to diastolic heart failure
UA52107U (en) Method for surgical treatment of pulmonary tuberculosis
MY162322A (en) Polysaccharide polymer from the seeds of the tamarind tree for use in treating dry cough
UA59839U (en) Method for fractional washing of abdominal cavity in peritonitis

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)